ADCC-Inducing Antibody Trastuzumab and Selection of KIR-HLA Ligand Mismatched Donors Enhance the NK Cell Anti-Breast Cancer Response

SIMPLE SUMMARY: Natural killer (NK) cells are potent killers of tumor cells. Many tumors, including breast cancers, develop mechanisms to suppress anti-tumor immune responses, requiring the development of strategies to overcome suppression. Here, we tested a combination therapy that aims to (1) enha...

Descripción completa

Detalles Bibliográficos
Autores principales: Ehlers, Femke A. I., Beelen, Nicky A., van Gelder, Michel, Evers, Tom M. J., Smidt, Marjolein L., Kooreman, Loes F. S., Bos, Gerard M. J., Wieten, Lotte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268223/
https://www.ncbi.nlm.nih.gov/pubmed/34203549
http://dx.doi.org/10.3390/cancers13133232

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268223/
https://www.ncbi.nlm.nih.gov/pubmed/34203549
http://dx.doi.org/10.3390/cancers13133232

Ejemplares similares